EUVIMEDEUVIMED entdecken
Crossref

Spinocerebellar Ataxia Progression Measured with the Patient‐Reported Outcome Measure of Ataxia

Anna L Burt, Gilbert L'Italien, Susan L Perlman, Liana S Rosenthal iD, Sheng-Han Kuo, Tetsuo Ashizawa iD, Theresa Zesiewicz iD, Cameron Dietiker, Puneet Opal, Antoine Duquette, George R Wilmot, Vikram G Shakkottai und 14 weitere

Movement Disorders · 2025-05 · 40 (5) · 917-927

DOI: 10.1002/mds.30158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 04.03.2025. Verfasst von Anna L Burt und 25 weiteren Autor:innen. Beteiligte Einrichtung: Ataxia Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Disease Progression, Patient Reported Outcome Measures, Spinocerebellar Ataxias. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: MINDlink Foundation, NINDS NIH HHS, Great Oaks Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Patient‐Reported Outcome Measure of Ataxia (PROM‐Ataxia) has been validated cross‐sectionally but not longitudinally.

Objective

We aimed to validate PROM‐Ataxia as a measure of patient experience of disease over time, examine overall and domain‐specific progression, and test convergent validity with other clinical outcome assessments (COAs).

Methods

We derived PROM‐Ataxia data from 176 patients with spinocerebellar ataxia types 1, 2, 3, 6, 7, 8, or 10 in the Clinical Research Consortium for the Study of Cerebellar Ataxia at baseline and 1 year. We classified patients' ataxia severity stage (“severity”) according to the Friedreich's Ataxia Rating Scale Functional Staging into mild , moderate , and severe subgroups. Analyses of the entire cohort and by severity subgroup included internal consistency, sensitivity to disease severity, predictive modeling of score changes, correlations with COAs: Brief Ataxia Rating Scale, Scale for Assessment and Rating of Ataxia, Fatigue Severity Scale, Cerebellar Cognitive Affective Syndrome scale, EuroQol 5‐Dimension, and responsiveness to disease progression.

Results

The PROM‐Ataxia exhibited high internal consistency and correlated with other COAs. Scores demonstrated sensitivity to disease severity and evolving patient experience. Progression was sigmoidal, with the greatest change in moderate patients. Compared with other COAs, PROM‐Ataxia captured the most change. Mental features worsened fastest in mild patients, physical in moderate patients, and activities of daily living in severe patients.

Conclusion

PROM‐Ataxia is more sensitive to change than ataxia COAs, captures the evolution of patients' experience of disease over 1 year, and reveals domain‐specific progression. Studies of larger cohorts and different ataxia diagnoses over longer periods may provide insights to further enhance clinical care and research. © 2025 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionPatient Reported Outcome MeasuresSpinocerebellar AtaxiasHumansMaleFemaleMiddle AgedAdultSeverity of Illness IndexAgedYoung Adult

Stichwörter der Autor:innen

PROM‐ataxiacerebellar cognitive affective syndromecerebellumclinical outcome assessmentprogressionspinocerebellar ataxia

Autor:innen und Institutionen

  • Ataxia Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Biohaven Pharmaceuticals, New Haven, Connecticut, USA.
  • Department of Neurology, University of California, Los Angeles, California, USA.
  • Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology, Columbia University Medical Center, New York City, New York, USA.
  • Stanley H. Appel Department of Neurology, Houston Methodist Hospital, Houston, Texas, USA.

ORCID-Profile: Liana S Rosenthal, Tetsuo Ashizawa, Theresa Zesiewicz, Marie Y Davis, Anoopum Gupta, Christopher D Stephen, Jeremy D Schmahmann

Förderung

  • MINDlink Foundation
  • NINDS NIH HHS
  • Great Oaks Foundation
  • Once Upon A Time Foundation
  • National Ataxia Foundation

Zitieren

APA

Burt, A. L., L'Italien, G., Perlman, S. L., Rosenthal, L. S., Kuo, S. H., Ashizawa, T., Zesiewicz, T., Dietiker, C., Opal, P., Duquette, A., Wilmot, G. R., Shakkottai, V. G., Gomez, C. M., Srinivasan, S. R., Paulson, H., Geschwind, M. D., Worley, S., Onyike, C. U., Billnitzer, A., …, & Schmahmann, J. D. (2025). Spinocerebellar Ataxia Progression Measured with the Patient‐Reported Outcome Measure of Ataxia. Movement Disorders, 40(5), 917-927. https://doi.org/10.1002/mds.30158

Vancouver

Burt AL, L'Italien G, Perlman SL, Rosenthal LS, Kuo SH, Ashizawa T, et al. Spinocerebellar Ataxia Progression Measured with the Patient‐Reported Outcome Measure of Ataxia. Movement Disorders. 2025;40(5):917-927. doi:10.1002/mds.30158

BibTeX
@article{Burt2025,
  author = {Burt, Anna L and L'Italien, Gilbert and Perlman, Susan L and Rosenthal, Liana S and Kuo, Sheng-Han and Ashizawa, Tetsuo and Zesiewicz, Theresa and Dietiker, Cameron and Opal, Puneet and Duquette, Antoine and Wilmot, George R and Shakkottai, Vikram G and Gomez, Christopher M and Srinivasan, Sharan R and Paulson, Henry and Geschwind, Michael D and Worley, Sandie and Onyike, Chiadi U and Billnitzer, Andrew and Ferng, Amy and Matulis, Kristen and Davis, Marie Y and Subramony, Sub H and Gupta, Anoopum and Stephen, Christopher D and Schmahmann, Jeremy D},
  title = {Spinocerebellar Ataxia Progression Measured with the Patient‐Reported Outcome Measure of Ataxia},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {5},
  pages = {917--927},
  doi = {10.1002/mds.30158}
}
Kostenlos starten →